Literature DB >> 12954489

Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe.

Francesco Panza1, Vincenzo Solfrizzi, Alessia D'Introno, Anna Maria Colacicco, Cristiano Capurso, Patrick G Kehoe, Antonio Capurso.   

Abstract

Variants of the angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (ACE1) gene and the apolipoprotein E gene (APOE) have been suggested to be associated with human longevity. We tested the association between the ACE1 insertion (I allele)/deletion (D allele) polymorphism and longevity in a population from Southern Italy and examined the impact of geographical variation on ACE1 allele frequencies on reported associations from other European countries. ACE1 and APOE genotypes were obtained on 82 centenarians and 252 middle-aged, unrelated subjects or volunteers. No statistically significant differences were found in ACE1 genotype or allele frequencies between centenarians and controls in this Southern Italian population nor was there any observed interaction with APOE alleles that are also reputed to be linked to longevity. However, decreasing gradients in ACE1*I allele frequencies, both in centenarians and controls, with concomitant increases in ACE1*D allele frequencies (particularly the ACE1*D/*D genotype) were observed to be statistically significant from Northern to Southern regions of Europe. These findings did not support the previously reported association between ACE1 polymorphism and longevity. However, there were interesting and significant differences, as one moves from Northern to Southern Europe, with regard to the distribution of ACE1 alleles. Such genetic differences in conjunction with differing environmental factors may explain in part previous results suggesting a role of this polymorphism in longevity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954489     DOI: 10.1016/s0531-5565(03)00154-2

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  8 in total

1.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

2.  Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.

Authors:  Davide Seripa; Francesco Panza; Giulia Paroni; Grazia D'Onofrio; Paola Bisceglia; Carolina Gravina; Maria Urbano; Madia Lozupone; Vincenzo Solfrizzi; Alessandra Bizzarro; Virginia Boccardi; Chiara Piccininni; Antonio Daniele; Giancarlo Logroscino; Patrizia Mecocci; Carlo Masullo; Antonio Greco
Journal:  Mol Neurobiol       Date:  2017-06-19       Impact factor: 5.590

Review 3.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

4.  Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans.

Authors:  Matea Zajc Petranović; Tatjana Skarić-Jurić; Nina Smolej Narančić; Zeljka Tomas; Petra Krajačić; Jasna Miličić; Maja Barbalić; Spomenka Tomek-Roksandić
Journal:  Age (Dordr)       Date:  2011-05-26

5.  Successful aging shows linkage to chromosomes 6, 7, and 14 in the Amish.

Authors:  Digna R Velez Edwards; John R Gilbert; Lan Jiang; Paul J Gallins; Laura Caywood; Marilyn Creason; Denise Fuzzell; Clare Knebusch; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines; William K Scott
Journal:  Ann Hum Genet       Date:  2011-07       Impact factor: 1.670

6.  Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients.

Authors:  Alberto Pilotto; Maria G Matera; Luigi Ferrucci; Daniele Sancarlo; Gioacchino Leandro; Grazia D'Onofrio; Davide Seripa; Filomena Addante; Marilisa Franceschi; Bruno Dallapiccola
Journal:  Rejuvenation Res       Date:  2009-08       Impact factor: 4.663

Review 7.  We are ageing.

Authors:  Genovefa D Kolovou; Vana Kolovou; Sophie Mavrogeni
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

Review 8.  ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations.

Authors:  Eric M Snyder; Bruce D Johnson
Journal:  Pharmacogenomics       Date:  2020-06-05       Impact factor: 2.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.